Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)
Authors:
Top Cited Papers
Open Access
- 24 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (12) , 5901-5910
Abstract
Although targeting TfR1 to deliver oligonucleotides to skeletal muscle has been demonstrated in rodents, effectiveness and pharmacokinetic/pharmacodynamic (PKPD) properties remained unknown in higher species. We developed antibody–oligonucleotide conjugates (AOCs) towards mice or monkeys utilizing anti-TfR1 monoclonal antibodies (αTfR1) conjugated to various classes of oligonucleotides (siRNA, ASOs and PMOs). αTfR1 AOCs delivered oligonucleotides to muscle tissue in both species. In mice, αTfR1 AOCs achieved a > 15-fold higher concentration to muscle tissue than unconjugated siRNA. A single dose of an αTfR1 conjugated to an siRNA against Ssb mRNA produced > 75% Ssb mRNA reduction in mice and monkeys, and mRNA silencing was greatest in skeletal and cardiac (striated) muscle with minimal to no activity in other major organs. In mice the EC50 for Ssb mRNA reduction in skeletal muscle was >75-fold less than in systemic tissues. Oligonucleotides conjugated to control antibodies or cholesterol produced no mRNA reduction or were 10-fold less potent, respectively. Tissue PKPD of AOCs demonstrated mRNA silencing activity primarily driven by receptor-mediated delivery in striated muscle for siRNA oligonucleotides. In mice, we show that AOC-mediated delivery is operable across various oligonucleotide modalities. AOC PKPD properties translated to higher species, providing promise for a new class of oligonucleotide therapeutics.Keywords
Funding Information
- Avidity Biosciences, Inc
This publication has 33 references indexed in Scilit:
- Worth the RISC?Nature Biotechnology, 2017
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal musclesJournal of Controlled Release, 2016
- Lipid nanoparticles for targeted siRNA delivery – going from bench to bedsideInternational Journal of Nanomedicine, 2016
- Metabolic Catastrophe in Mice Lacking Transferrin Receptor in MuscleEBioMedicine, 2015
- Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino OligonucleotidesNucleic Acid Therapeutics, 2015
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applicationsJournal of Controlled Release, 2015
- Evaluation of 2’-Deoxy-2’-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular DystrophyMolecular Therapy Nucleic Acids, 2015
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugatesNucleic Acids Research, 2014
- Real-time quantification of microRNAs by stem-loop RT-PCRNucleic Acids Research, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001